Jonas Saal

5PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersInnate immunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 09, 2026
Integrating NECTIN4 Amplification With Membranous Nectin-4 Expression to Develop a Scoring System for Predicting Enfortumab Vedotin Response in Urothelial Carcinoma.

|Dec 16, 2024
C-Reactive Protein Facilitates Premetastatic Niche Formation in the Lungs.

Jonas Saal, Niklas Klümper, Michael Hölzel

|Apr 24, 2024
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.

Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz

|Nov 10, 2023
Pretreatment albumin is a prognostic and predictive biomarker for response to atezolizumab across solid tumors.

Jonas Saal, Jörg Ellinger, Manuel Ritter

|Jun 22, 2022
Two cases of EBV infection preceding lymphoma.

Jonas Saal, Busher Aboudan, Peter Brossart

Pageof 1

Frequent Collaborators

3 joint publications

Michael Hölzel

3 joint publications

Niklas Klümper

2 joint publications

Camilla Marisa Grunewald

2 joint publications

Oliver Hahn